Taysha Gene Therapies
TSHA
TSHA
105 hedge funds and large institutions have $354M invested in Taysha Gene Therapies in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 108 → 105 (-3)
12% less capital invested
Capital invested by funds: $402M → $354M (-$47.9M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
105
Holding in Top 10
1
Calls
$208K
Puts
$99K
Top Buyers
| 1 | +$20.5M | |
| 2 | +$6.67M | |
| 3 | +$6.43M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.68M |
| 5 |
Morgan Stanley
New York
|
+$5.17M |
Top Sellers
| 1 | -$6.67M | |
| 2 | -$6.26M | |
| 3 | -$4.45M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.19M |
| 5 |
SC
Stempoint Capital
New York
|
-$3.12M |